Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...

Children seem to be less likely to be obese if they live at high altitude, which may be due to its effect on metabolism and ...

Superluminal Medicines said on Thursday it had signed a deal with U.S. drugmaker Eli Lilly worth up to $1.3 billion to ...

While autism itself has no single cause, researchers say their findings help us understand how early life factors can shape ...

Combining liraglutide with a very low-calorie ketogenic diet can lead to greater weight loss than the diet alone in adults ...

This study suggests that weight loss before pursuing IVF may improve pregnancy rates for women with obesity. Losing weight ...

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...

The updated obesity guidelines emphasize that, in addition to supporting weight loss, drug treatments can also enhance ...

Tiny "hidden" proteins lurking in DNA once dismissed as junk may hold the key to the next generation of obesity drugs, ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, ...

While it’s been easy to grow a bit desensitized to the seemingly unstoppable sales growth of Novo Nordisk and Eli Lilly’s | ...